Severe rhinorrhea and respiratory distress in a neonate exposed to fluphenazine hydrochloride prenatally

Annals of Pharmacotherapy

Volumn 30, Issue 1, 1996, Pages 35-37

  Nath, Shanta P ^a,b   Miller, Debra A ^c   Muraskas, Jonathan K ^c  

^a La Grange Memorial Hospital ^*  (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c LOYOLA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUPHENAZINE; PSEUDOEPHEDRINE;

ADULT; ARTICLE; CASE REPORT; DRUG SAFETY; FEMALE; HUMAN; NEWBORN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RHINORRHEA; SCHIZOPHRENIA; VOMITING;

EID: 0030045022     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000106     Document Type: Article

References (19)

1. Fluphenazine. In: McEvoy GK, ed. AHFS 95 drug information. Bethesda. MD: American Society of Health-System Pharmacists. 1995:1513.
2. Gelenberg AJ. Pregnancy, psychotropic drugs, and psychiatric disorders. Psychosomatics 1986;27:216-7.
3. O'Connor M, Johnson GH, James DI. Intrautenne effect of phenothiazines. Med J Aust 1981;1:416-7.
4. Cleary MF. Fluphenazine decanoate during pregnancy. Am J Psychiatry 1977;134.8156.
5. Mortola JF. The use of psychotropic agents in pregnancy and lactation. Psychiatr Clin North Am 1989;12:69-87.
6. Szabo KT, Brent RL. Species differences in experimental teratogenesis by tranquillizing agents (letter). Lancet 1974;1:565.
7. Rumeau-Roquette C, Huel G. Possible teratogenic effect of phenothiazmes in human beings. Teratology 1977;15:57-64
8. Miklovich L, Van den Berg BJ An evaluation of the teratogenicity of certain antinauseant drugs. Am J Obstet Gynecol 1976;125:244-8.
9. Slone D, Siskind V, Heinonen OP, Monson RR, Kaufman DW, Shapiro S. Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol 1977;128:486-8.
10. Donaldson GL, Bury RG. Multiple congenital abnormalities in a newborn boy associated with maternal use of fluphenazine enanthate and other drugs during pregnancy. Acta Paediatr Scand 1982;71:335-8.
11. Hill RM, Desmond MM, Kay TI. Extrapyramidal dysfunction in an infant of a schizophrenic mother. J Pediatr 1966;69:589-95.
12. Orfan NA, Kolsi GB. Rhinorrhea related to antipsychotic drug therapy. J Allergy Clin Immunol 1993;91:681-2.
13. McClelland HA, Blessed G, Bhate S, Ali N, Clarke PA. The abrupt withdrawal of anti-parkinson drugs in schizophrenic patients. Br J Psychiatry 1974;124:151-9.
14. Johnson DAW. The side-effects of fluphenazine decanoate. J Psychiatry 1973;123:519-22.
15. Dysken MW, Javaid JI, Chang SS, Schaffer C, Shahid A, Davis JM. Fluphenazine pharmacokinetics and therapeutic response. Psychopharmacology 1981;73.205-10.
16. Simpson GM, Yadalam KG, Levinson DF, Stephanos MJ, Lo ES, Cooper TB. Single dose pharmacokinetics of fluphenazine after fluphenazine decanoate admmistralion. J Clin Psychopharmacol 1990;10:417-21.
17. Jann NW, Ereshefsky L, Saklad SR. Clinical pharmacokinetics of the depot antipsychotics. Clin Pharmacokinet 1985;10:315-33.
18. 12C in the dos and rhesus monkey. J Pharm Sci 1971;60.829-33.
19. Mavroidis ML, Kanter DR, Hirschowitz J, Garver DL. Fluphenazine plasma levels and ciinical response. J Clin Psychiatry 1984;45:370-3.